Art

J-GLOBAL ID：201902260441674487   Reference number：19A2041416

Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study

転移性腎細胞癌患者に対するサイトカイン対第一線スニチニブと第二線アキシチニブの有効性と安全性:第III相無作為化逐次オープンラベル研究のための研究プロトコル【JST・京大機械翻訳】

Author (12)： Kadono Yoshifumi (Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan) ,  Konaka Hiroyuki (Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan) ,  Izumi Kouji (Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan) ,  Anai Satoshi (Department of Urology, Nara Medical University, Kashihara-Shi, Nara, Japan) ,  Fujimoto Kiyohide (Department of Urology, Nara Medical University, Kashihara-Shi, Nara, Japan) ,  Ishibashi Kei (Department of Urology, Fukushima Medical University, Fukushima, Japan) ,  Kawai Noriyasu (Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan) ,  Kato Taku (Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan) ,  Iba Akinori (Department of Urology, Wakayama Medical University, Wakayama, Japan) ,  Masumori Naoya (Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan) ,  Yoshimura Kenichi (Innovative Clinical Research Center (iCREK), Kanazawa University Hospital, Kanazawa, Japan) ,  Mizokami Atsushiu (Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan)
Material： Contemporary Clinical Trials Communications
Volume： 15  Page： Null  Publication year： 2019 
JST Material Number： W3102A  ISSN： 2451-8654  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Appropriate protocol for the s...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2041416&from=J-GLOBAL&jstjournalNo=W3102A") }}

Thesaurus term： *safety ,  *effectiveness ,  durability ,  therapy ,  *cytokine ,  interleukin ,  *protocol ,  interferon alpha ,  randomized controlled trial ,  enzyme inhibitor ,  molecular targeting drug
Semi thesaurus term： 第二選択療法 ,  第一選択療法 ,  完全寛解 ,  *転移性腎細胞癌 , 【Automatic Indexing@JST】

Author keywords (6)： Cytokine ,  Interferon alfa ,  Interleukin-2 ,  Sunitinib ,  Axitinib ,  Metastatic renal cell carcinoma

JST classification (2)： Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Medical systems  (GB04020H)

Substance index (2)： Axitinib ,  Sunitinib

Terms in the title (11)： 転移性腎細胞癌 ,  患者 ,  サイトカイン ,  スニチニブ ,  アキシチニブ ,  有効性 ,  安全性 ,  逐次 ,  ラベル ,  研究 ,  プロトコル